S Stavchansky
Overview
Explore the profile of S Stavchansky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newburger J, Stavchansky S, Pearlman R
J Pharm Sci
. 2011 May;
69(10):1331-2.
PMID: 21618214
The estimates of infinity values obtained using Prony's method are shown to be subject to significant error arising from small errors in the assigned sample times. The error of the...
2.
Strauch S, Jantratid E, Dressman J, Junginger H, Kopp S, Midha K, et al.
J Pharm Sci
. 2011 Apr;
100(6):2054-63.
PMID: 21491435
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing lamivudine as...
3.
Olivera M, Manzo R, Junginger H, Midha K, Shah V, Stavchansky S, et al.
J Pharm Sci
. 2010 Jul;
100(1):22-33.
PMID: 20602455
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage...
4.
Strauch S, Jantratid E, Dressman J, Junginger H, Kopp S, Midha K, et al.
J Pharm Sci
. 2010 Jul;
100(1):11-21.
PMID: 20602454
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release solid oral dosage forms containing mefloquine hydrochloride as...
5.
Granero G, Longhi M, Mora M, Junginger H, Midha K, Shah V, et al.
J Pharm Sci
. 2009 Dec;
99(6):2544-56.
PMID: 19960529
Literature and new experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms...
6.
Jantratid E, Strauch S, Becker C, Dressman J, Amidon G, Junginger H, et al.
J Pharm Sci
. 2009 Oct;
99(4):1639-53.
PMID: 19798752
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing doxycycline hyclate...
7.
Becker C, Dressman J, Junginger H, Kopp S, Midha K, Shah V, et al.
J Pharm Sci
. 2009 Jan;
98(7):2252-67.
PMID: 19160441
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage...
8.
Grube S, Langguth P, Junginger H, Kopp S, Midha K, Shah V, et al.
J Pharm Sci
. 2008 Nov;
98(7):2238-51.
PMID: 18979535
Literature data are reviewed relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid...
9.
Chuasuwan B, Binjesoh V, Polli J, Zhang H, Amidon G, Junginger H, et al.
J Pharm Sci
. 2008 Aug;
98(4):1206-19.
PMID: 18752289
Literature data are reviewed regarding the scientific advisability of allowing a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing...
10.
Arnal J, Gonzalez-Alvarez I, Bermejo M, Amidon G, Junginger H, Kopp S, et al.
J Pharm Sci
. 2008 Apr;
97(12):5061-73.
PMID: 18425814
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing (biowaiver) for the approval of immediate release (IR) solid oral dosage forms containing aciclovir...